Report : Human Microbiome Market to 2025 - Global Analysis and Forecasts by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others), Application (Therapeutics and Diagnostics), and Geography
Probiotics Segment is expected to grow the Market for Human Microbiome over the Forecast Period for Product Segment.
According to a new market research study titled ‘Human Microbiome Market to 2025 - Global Analysis and Forecasts by Product, Disease and Application. The global human microbiome market is expected to reach US$ 1,197.08 Mn in 2025 from US$ 257.30 Mn in 2017. The market is estimated to grow with a CAGR of 21.8% from 2018-2025. The report highlights the trends prevalent in the global human microbiome market and the factors driving the market along with those that act as deterrents to its growth.
The product segment of the human microbiome market is broadly segmented into food, medical foods, probiotics, prebiotics, drugs, diagnostic devices and supplements. In 2017, the probiotics segment held the largest share of the market, by product. However, the prebiotics is expected to grow at the fastest CAGR during the forecast period owing to growing demand for fiber rich food products is expected to drive the market. Additionally, rising investment in the food & beverage industry for innovation and development of new food products enriched with prebiotics.
The market for human microbiome is expected to grow as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies and growing technological advancements in metagenomics and next-generation sequencing are expected to fuel the market growth during the forecast period. In addition, the human microbiome - a new frontier in drug discovery is likely to have a positive impact on the growth of the market in the coming years.
The major players operating in the human microbiome market include Enterome, MicroBiome Therapeutics, LLC, Rebiotix Inc., Yakult Honsha Co., Ltd., Osel Inc., Vedanta Biosciences, Inc., Metabiomics Corporate, Synthetic Biologics, Inc., DuPont, and BiomX Ltd. For instance, in April 2018, MicroBiome Therapeutics, LLC (MBT), announced the launch of BiomeBliss, a patented, first-in-class prebiotic dietary supplement specifically developed to support a healthy gastrointestinal (GI) microbiome. Developed by pioneering researchers and entrepreneurs, BiomeBliss nourishes, shifts and protects the GI microbiome ? the trillions of gut bacteria that affect health. The developments performed by the companies are helping the market to grow in the coming years.
The report segments the global human microbiome market as follows:
Global Human Microbiome Market - By Product
Global Human Microbiome Market - By Disease
Global Human Microbiome Market - By Application
Global Human Microbiome Market - By Geography
Asia Pacific (APAC)
Middle East & Africa (MEA)
South & Central America (SCAM)
Contact Person: Sameer Joshi
Email Id: email@example.com